Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 24;12(2):138.
doi: 10.3390/v12020138.

Smallpox in the Post-Eradication Era

Hermann Meyer  1 , Rosina Ehmann  1 , Geoffrey L Smith  2
Affiliations
Review

Smallpox in the Post-Eradication Era

Hermann Meyer et al. Viruses. .

Abstract

Widespread vaccination programmes led to the global eradication of smallpox, which was certified by the World Health Organisation (WHO), and, since 1978, there has been no case of smallpox anywhere in the world. However, the viable variola virus (VARV), the causative agent of smallpox, is still kept in two maximum security laboratories in Russia and the USA. Despite the eradication of the disease smallpox, clandestine stocks of VARV may exist. In a rapidly changing world, the impact of an intentional VARV release in the human population would nowadays result in a public health emergency of global concern: vaccination programmes were abolished, the percentage of immunosuppressed individuals in the human population is higher, and an increased intercontinental air travel allows for the rapid viral spread of diseases around the world. The WHO has authorised the temporary retention of VARV to enable essential research for public health benefit to take place. This work aims to develop diagnostic tests, antiviral drugs, and safer vaccines. Advances in synthetic biology have made it possible to produce infectious poxvirus particles from chemicals in vitro so that it is now possible to reconstruct VARV. The status of smallpox in the post-eradication era is reviewed.

Keywords: antiviral; eradication; smallpox; vaccination; variola virus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest

References

    1. Henderson D.A., Inglesby T.V., Bartlett J.G., Ascher M.S., Eitzen E., Jahrling P.B., Hauer J., Layton M., McDade J., Osterholm M.T., et al. Smallpox as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense. JAMA. 1999;281:2127–2137. doi: 10.1001/jama.281.22.2127. - DOI - PubMed
    1. Wehrle F., Posch J., Richter K.H., Henderson D.A. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull. World Health Organ. 1970;43:669–679. - PMC - PubMed
    1. Damon I.K., Esposito J.J. Poxviruses that infect humans. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., Yolker M.H., editors. Manual of Clinical Microbiology. 8th ed. ASM Press; Washington, DC, USA: 2003. pp. 1583–1591.
    1. Evaluating Patients for Smallpox: Acute, Generalized Vesicular or Pustular Rash Illness Protocol. [(accessed on 24 January 2020)]; Available online: https://www.cdc.gov/smallpox/clinicians/algorithm-protocol.html.
    1. Smallpox. [(accessed on 24 January 2020)]; Available online: https://www.cdc.gov/smallpox/